HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): William Holman Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, P. Articles by Holman, W. Search for Related Content PubMed PubMed Citation Articles by Wang, P. Articles by Holman, W. Related Collections Myocardial protection Related Article

Ann Thorac Surg 2007;83:1121-1127
© 2007 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Sodium–Hydrogen Exchange Inhibition and ß-Blockade Additively Decrease Infarct Size

^a Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama
^b Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama
^c Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama

Accepted for publication October 16, 2006.

^_* Address correspondence to Dr Holman, Department of Surgery, Room 719, 703 19th St S, Birmingham, AL 35294-0007 (Email: wholman{at}its.uab.edu).

Background: Perioperative myocardial infarction adversely affects survival after cardiac operations. In animal studies Na⁺/H⁺ exchange inhibitors protect hearts against ischemia–reperfusion injury, but human trials have failed to consistently show beneficial effects. The aim of this study was to investigate whether the combination of the Na⁺/H⁺ exchange inhibitor cariporide and the ß-blocker metoprolol additively protects hearts from severe ischemia–reperfusion injury.

Methods: Isolated Langendorff-perfused rat hearts were randomly assigned to a vehicle-treated control group, or groups with 10-minute preischemia infusions of cariporide (10 µmol/L), metoprolol (10 µmol/L), or both cariporide and metoprolol. The hearts were then subjected to 20 minutes of global ischemia followed by 60 minutes of reperfusion. At the end of reperfusion, the hearts were randomly assigned to undergo either infarct size measurements or left ventricular mitochondrial function analyses.

Results: The combination of cariporide and metoprolol limited infarct size significantly compared with control group or cariporide alone (5% ± 1% versus 58% ± 9% or 38.4% ± 4% of risk zone; p < 0.05). Cariporide alone did not reduce infarct size significantly as compared with the control group. As compared with the control group, cariporide and metoprolol decreased mitochondrial calcium content (6.4 ± 1.2 versus 10.2 ± 1.1 nmol/mg protein; p < 0.05), and increased respiratory control ratio (9.5 ± 0.6 versus 5.3 ± 0.7; p < 0.05). However, hearts treated with cariporide or metoprolol alone did not show significant improvement in mitochondrial calcium content (7.8 ± 1.2 and 7.8 ± 1.5 nmol/mg protein) or respiratory control ratio (5.0 ± 0.7 and 7.3 ± 0.7).

Conclusions: The combination of cariporide and metoprolol additively limits infarct size after severe ischemia–reperfusion injury in an isolated rat heart model. Infarct size reduction occurs in association with protection from increased mitochondrial calcium content after reperfusion.

Related Article

Invited commentary

Steven Anderson
Ann. Thorac. Surg. 2007 83: 1128. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				S. Anderson Invited commentary Ann. Thorac. Surg., March 1, 2007; 83(3): 1128 - 1128. [Full Text] [PDF]